Han-Joo Baek

Efficacy and safety of PG201 (Layla®) and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study

Wan‐Hee Yoo, Han-Gyul Yoo, Sung‐Hwan Park et al. · Rheumatology International · 2014 · 24 citations

Medicine, Pharmacology, Pharmacotherapy +6

Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial

In Ah Choi, Han-Joo Baek, Chul-Soo Cho et al. · BMC Musculoskeletal Disorders · 2014 · 19 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Paclitaxel reduces anti-dsDNA antibody titer and bun, prolonging survival in murine lupus

Yeong Wook Song, Hyun‐Ah Kim, Han-Joo Baek et al. · International Journal of Immunopharmacology · 1998 · 16 citations

Life Sciences, Immunology, Pharmacology +8

Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial

Myung Chul Yoo, Wan Hee Yoo, Seung Baek Kang et al. · Current Medical Research and Opinion · 2014 · 15 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Induction of Remission is Difficult due to Frequent Relapse during Tapering Steroids in Korean Patients with Polymyalgia Rheumatica

Hyoun‐Ah Kim, Jisoo Lee, You‐Jung Ha et al. · Journal of Korean Medical Science · 2011 · 15 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14